Asymchem Laboratories (Tianjin) Co., Ltd. is a globally recognized Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical industry. They offer integrated solutions across the drug lifecycle, including clinical-stage R&D, commercial manufacturing of APIs (Active Pharmaceutical Ingredients) and drug products, and emerging services like biologics and clinical research. Asymchem is committed to innovation, quality, and sustainability, partnering with pharmaceutical companies worldwide to bring life-saving medicines to patients.
Serves as the central hub for strategic decision-making, global operations management, core research and development activities, and corporate functions.
Features state-of-the-art R&D laboratories, cGMP-compliant manufacturing facilities for APIs and drug products, and modern administrative offices designed to foster collaboration and scientific innovation.
Emphasizes scientific excellence, a culture of continuous improvement, robust quality systems, client-centricity, and teamwork, fostering an environment conducive to learning and professional development in the pharmaceutical sciences.
The TEDA headquarters is pivotal to Asymchem's global strategy, housing significant research capabilities and advanced manufacturing assets, enabling the company to serve a worldwide clientele and drive pharmaceutical innovation.
Asymchem supports pharmaceutical and biotech clients globally through its strategically located R&D centers, manufacturing facilities, and business development offices across China, the United States, and with outreach to Europe. This integrated network enables comprehensive end-to-end CDMO services, including process R&D, API manufacturing (from laboratory scale to large-scale commercial production), formulation development, drug product manufacturing (oral solids, injectables), clinical research services, and specialized biologics CDMO services. Their global footprint ensures close collaboration with international clients and adherence to global quality standards (e.g., FDA, EMA, NMPA, PMDA).
No. 71, 9th Avenue, Tianjin Economic-Technological Development Area (TEDA)
Tianjin
Tianjin
China
Address: 600 Airport Blvd, Suite 400, Morrisville, NC 27560, USA
Serves as a key interface for the North American pharmaceutical market, providing localized support, fostering partnerships, and aligning global capabilities with regional client needs.
Address: Dunhua Economic Development Zone, Jilin Province, China
Functions as a critical production base within Asymchem's global manufacturing network, supporting the worldwide supply chain for late-stage clinical and commercial drug substances with high-volume capacity.
Address: Fluorochemical Industry Park, Fuxin, Liaoning Province, China
Strengthens Asymchem's vertical integration by providing critical starting materials and intermediates, ensuring supply chain security and cost-effectiveness for complex pharmaceutical projects.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Asymchem Group' leadership includes:
Asymchem Group has been backed by several prominent investors over the years, including:
In the past 12 months, Asymchem has experienced changes at the board level, primarily in early 2024. These include the resignation of a non-executive director and an independent non-executive director, alongside the appointment of a new independent non-executive director, indicating routine governance adjustments.
Discover the tools Asymchem Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Asymchem's corporate email format generally follows common patterns. For general inquiries, they use functional email addresses (e.g., BD@asymchem.com, IR_Asia@asymchem.com). For individual employees, formats typically combine parts of their names.
[first_initial][last_name]@asymchem.com or [first_name].[last_name]@asymchem.com
Format
jdoe@asymchem.com
Example
70%
Success rate
PR Newswire • March 28, 2024
Asymchem announced its financial results for the fiscal year ended December 31, 2023. The company highlighted revenue from emerging services and ongoing investments in global capacity and R&D, navigating a dynamic market environment....more
HKEX News • March 29, 2024
Asymchem filed an announcement regarding changes to its Board of Directors, including the resignation of Mr. Wang Qingde (Non-Executive Director), Mr. Zhang Guodong (Independent Non-Executive Director), and the appointment of Ms. Margaret Pen as an Independent Non-Executive Director, effective March 29, 2024....more
Business Wire • August 2, 2023
Asymchem's primary manufacturing and R&D site in Tianjin successfully completed a U.S. Food and Drug Administration (FDA) on-site inspection. This marks the first FDA inspection at the site since before the pandemic, reaffirming its adherence to global cGMP quality standards....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Asymchem Group, are just a search away.